Literature DB >> 4862277

Unfavourable reactions to LSD: a review and analysis of the available case reports.

R G Smart, K Bateman.   

Abstract

Mesh：

Substances：

Year:  1967        PMID： 4862277      PMCID： PMC1923615     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  21 in total

Review 1.  THE EFFICACY OF LSD IN THE TREATMENT OF ALCOHOLISM.

Authors:  R G SMART; T STORM
Journal:  Q J Stud Alcohol       Date:  1964-06

2.  PATTERNS OF HALLUCINOGENIC DRUG ABUSE.

Authors:  A M LUDWIG; J LEVINE
Journal:  JAMA       Date:  1965-01-11       Impact factor: 56.272

3.  LSD-TREATMENT. EXPERIENCE GAINED WITHIN A THREE-YEAR-PERIOD.

Authors:  E Geert-Joergensen; M Hertz; K Knudsen; K Kristensen
Journal:  Acta Psychiatr Scand       Date:  1964       Impact factor: 6.392

4.  Complications associated with lysergic acid diethylamide (LSD-25).

Authors:  S COHEN; K S DITMAN
Journal:  JAMA       Date:  1962-07-14       Impact factor: 56.272

5.  Lysergic acid diethylamide and related substances.

Authors:  E ROTHLIN
Journal:  Ann N Y Acad Sci       Date:  1957-03-14       Impact factor: 5.691

6.  The resolution and subsequent remobilization of resistance by LSD in psychotherapy.

Authors:  C SAVAGE
Journal:  J Nerv Ment Dis       Date:  1957 Jul-Sep       Impact factor: 2.254

7.  Experimental schizophrenia-like symptoms.

Authors:  M RINKEL; H J DeSHON; R W HYDE; H C SOLOMON
Journal:  Am J Psychiatry       Date:  1952-02       Impact factor: 18.112

8.  Untoward reactions to lysergic acid diethylamide (LSD) resulting in hospitalization.

Authors:  W A Frosch; E S Robbins; M Stern
Journal:  N Engl J Med       Date:  1965-12-02       Impact factor: 91.245

9.  Prolonged adverse reactions to LSD in psychotic subjects.

Authors:  M Fink; J Simeon; W Haque; T Itil
Journal:  Arch Gen Psychiatry       Date:  1966-11

10.  Chromosomal damage in human leukocytes induced by lysergic acid diethylamide.

Authors:  M M Cohen; M J Marinello; N Back
Journal:  Science       Date:  1967-03-17       Impact factor: 47.728
View more
  11 in total

Review 1.  Non-medical use of drugs with particular reference to youth.

Authors: 
Journal:  Can Med Assoc J       Date:  1969-12-27       Impact factor: 8.262

Review 2.  The chromosomal and teratogenic effects of lysergic acid diethylamide: a review of the current literature.

Authors:  R G Smart; K Bateman
Journal:  Can Med Assoc J       Date:  1968-10-26       Impact factor: 8.262

Review 3.  Illicit drug use among Canadian youth. II.

Authors:  J R Unwin
Journal:  Can Med Assoc J       Date:  1968-03-02       Impact factor: 8.262

4.  ["Flashback": spontaneous psychotic episodes in adolescence resulting from psychedelic drug use].

Authors:  H E Hasse; H Waldmann
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1971

5.  Complications of therapy with lysergide.

Authors:  R Denson
Journal:  Can Med Assoc J       Date:  1969-11-29       Impact factor: 8.262

6.  Hallucinogenic drug abuse: manifestations and management.

Authors:  L P Solursh; W R Clement
Journal:  Can Med Assoc J       Date:  1968-02-24       Impact factor: 8.262

7.  LSD 'flashback' as a cause of diagnostic error.

Authors:  J A Smith; G Walters; D Johnston
Journal:  Postgrad Med J       Date:  1980-06       Impact factor: 2.401

8.  Flashbacks: a personal follow-up.

Authors:  F Holsten
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1976-12-30

Review 9.  Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies.

Authors:  Rafael G Dos Santos; José Carlos Bouso; Jaime E C Hallak
Journal:  Ther Adv Psychopharmacol       Date:  2017-02-23

10.  Comparison of Vitamin B12, Vitamin D, and Folic Acid Blood Levels in Plumbism Patients and Controls in Eastern Iran.

Authors:  Omid Mehrpour; Marzieh Modi; Borhan Mansouri; Nemam Ali Azadi; Samaneh Nakhaee; Alireza Amirabadi; Gholamreza Anaei-Sarab; Farshad M Shirazi; Stephanie T Weiss
Journal:  Biol Trace Elem Res       Date:  2020-03-21       Impact factor: 3.738
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.